Advisory Services Network, LLC Homology Medicines, Inc. Transaction History

Advisory Services Network, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.53 - $1.14 $368 - $793	696 New	696 $0
Q4 2022 Feb 13, 2023	BUY	$1.09 - $2.04 $49 - $91	45 New	45 $0
Q3 2021 Nov 05, 2021	SELL	$6.01 - $8.71 $56,163 - $81,394	-9,345 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$6.02 - $9.64 $56,256 - $90,085	9,345 New	9,345 $68,000
Q1 2021 May 24, 2021	SELL	$9.17 - $14.8 $412 - $666	-45 Closed	0 $0

Q4 2020 Feb 09, 2021	SELL	$8.92 - $13.29 $2,676 - $3,986	-300 Reduced 86.96%	45 $1,000
Q3 2020 Nov 16, 2020	BUY	$9.94 - $16.59 $3,429 - $5,723	345 New	345 $4,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.